Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study
Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very poor prognosis. But clinical studies have shown that drugs called ...
Feb 8, 2024
0
0